-
1
-
-
0031041588
-
s
-
s. J. Biol. Chem. 272:1997;5413-5420.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 5413-5420
-
-
Sun, H.1
Chen, Z.2
Poppleton, H.3
Scholich, K.4
Mullenix, J.5
Weipz, G.J.6
Fulgham, D.L.7
Bertics, P.J.8
Patel, T.B.9
-
2
-
-
0027403027
-
SH2 domains recognize specific phosphopeptide sequences
-
Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., Neel B.G., Birge R.B., Fajardo J.E., Chou M.M., Hanafusa H., Schaffhausen B., Cantley L.C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
-
(1993)
Cell
, vol.72
, pp. 767-778
-
-
Songyang, Z.1
Shoelson, S.E.2
Chaudhuri, M.3
Gish, G.4
Pawson, T.5
Haser, W.G.6
King, F.7
Roberts, T.8
Ratnofsky, S.9
Lechleider, R.J.10
Neel, B.G.11
Birge, R.B.12
Fajardo, J.E.13
Chou, M.M.14
Hanafusa, H.15
Schaffhausen, B.16
Cantley, L.C.17
-
3
-
-
0028146767
-
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
-
Nishikawa R., Ji X-D., Harmon R., Lazar C.S., Gill G.N., Cavenee W.K., Huang H-J.S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl Acad. Sci. (USA). 91:1994;7727-7730.
-
(1994)
Proc. Natl Acad. Sci. (USA)
, vol.91
, pp. 7727-7730
-
-
Nishikawa, R.1
Ji, X.-D.2
Harmon, R.3
Lazar, C.S.4
Gill, G.N.5
Cavenee, W.K.6
Huang, H.-J.S.7
-
4
-
-
0024543241
-
Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update
-
Marti U., Burwen S.J., Jones A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology. 9:1989;126-138.
-
(1989)
Hepatology
, vol.9
, pp. 126-138
-
-
Marti, U.1
Burwen, S.J.2
Jones, A.L.3
-
5
-
-
0029976245
-
Differential EGF receptor trafficking influences relative mitogenic potencies of epidermal growth factor and transforming growth factor α
-
Reddy C.C., Wells A., Lauffenburger D.A. Differential EGF receptor trafficking influences relative mitogenic potencies of epidermal growth factor and transforming growth factor α J. Cell Physiol. 166:1996;512-522.
-
(1996)
J. Cell Physiol.
, vol.166
, pp. 512-522
-
-
Reddy, C.C.1
Wells, A.2
Lauffenburger, D.A.3
-
6
-
-
0032387678
-
Epidermal growth factor receptor-mediated motility in fibroblasts
-
Wells A., Gupta K., Chang P., Swindle S., Glading A., Shiraha H. Epidermal growth factor receptor-mediated motility in fibroblasts. Microscopy Research and Technique. 43:1998;395-411.
-
(1998)
Microscopy Research and Technique
, vol.43
, pp. 395-411
-
-
Wells, A.1
Gupta, K.2
Chang, P.3
Swindle, S.4
Glading, A.5
Shiraha, H.6
-
7
-
-
0029758126
-
A role for gelsolin in actuating EGF receptor-mediated cell motility
-
Chen P., Murphy-Ullrich J., Wells A. A role for gelsolin in actuating EGF receptor-mediated cell motility. J. Cell. Biol. 134:1996;689-698.
-
(1996)
J. Cell. Biol.
, vol.134
, pp. 689-698
-
-
Chen, P.1
Murphy-Ullrich, J.2
Wells, A.3
-
8
-
-
0031939434
-
EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway
-
Xie H., Pallero M.A., Gupta D., Chang P., Ware M.F., Witke W., Kwiatkowski D.J., Lauffenburger D.A., Murphy-Ullrich J.E., Wells A. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCγ signaling pathway. J. Cell. Sci. 111:1998;615-624.
-
(1998)
J. Cell. Sci.
, vol.111
, pp. 615-624
-
-
Xie, H.1
Pallero, M.A.2
Gupta, D.3
Chang, P.4
Ware, M.F.5
Witke, W.6
Kwiatkowski, D.J.7
Lauffenburger, D.A.8
Murphy-Ullrich, J.E.9
Wells, A.10
-
9
-
-
0031022256
-
Anchorage-dependent cell cycle progression
-
Assoian R. Anchorage-dependent cell cycle progression. J. Cell. Biol. 136:1997;1-4.
-
(1997)
J. Cell. Biol.
, vol.136
, pp. 1-4
-
-
Assoian, R.1
-
10
-
-
0029898360
-
Mitogenic signaling from the EGF receptor is attenuated by a motility-associated phospholipase C-γ/protein kinase C feedback mechanism
-
Chen P., Xie H., Wells A. Mitogenic signaling from the EGF receptor is attenuated by a motility-associated phospholipase C-γ/protein kinase C feedback mechanism. Molec. Biol. Cell. 7:1996;871-881.
-
(1996)
Molec. Biol. Cell
, vol.7
, pp. 871-881
-
-
Chen, P.1
Xie, H.2
Wells, A.3
-
11
-
-
0021710145
-
Evidence for physiological function of epidermal growth factor: Pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period
-
Okamoto S., Oka T. Evidence for physiological function of epidermal growth factor: pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period. Proc. Natl Acad. Sci. (USA). 81:1984;6059-6063.
-
(1984)
Proc. Natl Acad. Sci. (USA)
, vol.81
, pp. 6059-6063
-
-
Okamoto, S.1
Oka, T.2
-
12
-
-
0031280262
-
Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development
-
Xie W., Paterson A.J., Chin E., Nabell L.M., Kudlow J.E. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Molec. Endocrinol. 11:1998;1766-1781.
-
(1998)
Molec. Endocrinol.
, vol.11
, pp. 1766-1781
-
-
Xie, W.1
Paterson, A.J.2
Chin, E.3
Nabell, L.M.4
Kudlow, J.E.5
-
13
-
-
0026316096
-
Growth factors and cancer
-
Aaronson S.A. Growth factors and cancer. Science. 254:1991;1146-1153.
-
(1991)
Science
, vol.254
, pp. 1146-1153
-
-
Aaronson, S.A.1
-
14
-
-
7144227965
-
Epidermal growth factor receptor (EGFR) and EGFR mutations, functions and possible role in clinical trials
-
Voldborg B.R., Damstrup L., Spang-Thomsen M., Poulsen H.S. Epidermal growth factor receptor (EGFR) and EGFR mutations, functions and possible role in clinical trials. Ann. Oncology. 8:1997;1197-1206.
-
(1997)
Ann. Oncology
, vol.8
, pp. 1197-1206
-
-
Voldborg, B.R.1
Damstrup, L.2
Spang-Thomsen, M.3
Poulsen, H.S.4
-
15
-
-
0029852598
-
Re-engineering epidermal growth factor for enhanced potency
-
Reddy C.C., Niyogi S.K., Wells A., Wiley H.S., Lauffenburger D.A. Re-engineering epidermal growth factor for enhanced potency. Nature Biotechnol. 14:1996;1696-1699.
-
(1996)
Nature Biotechnol.
, vol.14
, pp. 1696-1699
-
-
Reddy, C.C.1
Niyogi, S.K.2
Wells, A.3
Wiley, H.S.4
Lauffenburger, D.A.5
|